Episodios

  • Medical Resilience in Space | Dana Levin, MD, MPH
    Mar 18 2026
    Dana Levin, MD, MPH, serves as the medical director and chief flight surgeon for Vast Space. As the International Space Station plans for decommission in 2030, Vast Space is an industry pioneer with developing the first commercial space station, Haven-1, for long-term human habitation of low-Earth orbit. We discuss the implications of humans inhabiting space in this new frontier of opportunities, challenges, questions and implications for human health and medicine. Dana's background before his role at Vast includes working for NASA as a clinical scientist for the human research program, developing methods to assess medical risk for deep space missions and designing medical systems to mitigate them. He was also the clinical lead for NASA's artificial intelligence clinical decision support task force. Hosted by Bobby Gordon, MA, MBA This episode was recorded on Oct. 17, 2025, and information is current as of the time of this recording. Note, since recording, Vast has released a new launch timeline of 2027 for Haven-1.
    Más Menos
    27 m
  • The Intersection of AI and Medicine | Bruce Y. Lee, MD, MBA
    Mar 4 2026
    Our conversation this week is with Bruce Y. Lee, MD, MBA, a digital health and AI expert whose research focuses on AI systems modeling and other computer-aided approaches within the healthcare industry. Bruce has founded, built, and led multiple initiatives in systems science, AI, mathematical and computer modeling, digital health, operations research and science/health communications, including research consortia, centers at universities and independent companies. Hosted by Bobby Gordon, MA, MBA This episode was recorded on Oct. 15, 2025, and information presented herein is current at the time of recording.
    Más Menos
    43 m
  • Regenerative Medicine: From the Amazon Rainforest to Space | Alysson Muotri, PhD
    Feb 18 2026
    Our conversation with Alysson Muotri, PhD, covers a broad scope of topics including his innovative work and discoveries in space-based research, Neanderthal DNA, and groundbreaking breakthroughs in regenerative medicine and indigenous plants found in the Amazon Rainforest. Muotri serves as the director of the Sanford Integrated Space Stem Cell Orbital Research Center (ISSCOR) at UC San Diego's Sanford Stem Cell Institute, leading numerous research missions in sustained microgravity and low-Earth orbit. His work includes a focus on generating human disease models to determine the molecular and cellular mechanisms driving complex neurological disorders like autism and Alzheimer's disease, while identifying and testing novel therapeutic approaches. Hosted by Bobby Gordon, MA, MBA This episode was recorded on Oct. 2, 2025, and information presented is current as of the date of this recording.
    Más Menos
    33 m
  • Stem Cell Biology Industry Trends | Tiffani Manolis
    Feb 6 2026
    This episode features our conversation with Tiffani Manolis, vice president and general manager of the cell biology business at Thermo Fisher Scientific. Our discussion highlights her passion for cell biology and innovative trends in the gene and cell therapy industry, with a focus on advancing technologies that support the development of life-changing therapeutics. Tiffani is an experienced leader in the life sciences industry in her current role and joined Thermo Fisher Scientific in 2022 to lead the cell culture and cell therapy business. Prior to this role, Tiffani held various leadership positions at Agilent Technologies from 2015 to 2022, including vice president and general manager, and associate vice president of marketing for the chemistries division. Tiffani's career also includes significant roles at Bio-Rad Laboratories and USA Scientific. Hosted by Bobby Gordon, MA, MBA This episode was recorded on Oct. 16, 2025, and information presented is current as of this date.
    Más Menos
    26 m
  • RNA and Stem Cell Innovations | Gene Yeo, PhD, MBA
    Jan 21 2026
    Our conversation with Gene Yeo, PhD, MBA, features a deep dive into his innovative work with RNA, gene editing and intersection of stem cells and regenerative medicine. We discuss what's on the horizon for discoveries and industry-based opportunities. Yeo serves as the director of the Sanford Stem Cell Innovation Center with the goal to facilitate industry growth by leveraging research findings and developed technologies to support the commercialization of applications through strategic collaboration with industry partners. Yeo's work focuses on high-throughput genomics, systems biology approaches, engineering, and statistical and machine learning methods, as well as biochemical, molecular, and stem cell biology techniques, to solve problems in RNA processing. Hosted by Bobby Gordon, MA, MBA. This episode was recorded on Sept. 22, 2025, and all information is current as of the date of recording.
    Más Menos
    39 m
  • Stem Cell Clinical Trials: Behind the Scenes with Julissa Gonzalez at UC San Diego
    Jan 8 2026
    This episode features our conversation with Julissa Gonzalez, MS, who serves as the clinical research data manager at the UC San Diego Sanford Stem Cell Clinical Center. Her work helps frame and prepare insights into stem cell-related clinical trials. Our discussion explores information the public may not readily know about preparing for and administering therapeutics via clinical trials, including unique perspectives on validation, analyses, and patient care outcomes. This episode was recorded on June 2, 2025, and information is current as of the date of this recording. Hosted by Bobby Gordon, MA, MBA.
    Más Menos
    18 m
  • Conservation Genetics at the San Diego Zoo Wildlife Alliance | Marisa Korody, PhD
    Dec 17 2025
    Marisa Korody, PhD, serves San Diego Zoo Wildlife Alliance as a scientist in conservation genetics, working on the northern white rhino rescue project. She works closely with collaborators at The Scripps Research Institute to optimize the production of induced pluripotent stem cells (iPSCs) from banked rhino fibroblast cells in the Frozen Zoo® for potential use in assisted reproductive technologies. This episode was recorded on Aug. 13, 2025, and information is current as of the date of recording. Hosted by Bobby Gordon, MA, MBA.
    Más Menos
    30 m
  • The Evolution of DNA Editing and Stem Cells | Alexis Komor, PhD
    Dec 4 2025
    This episode features our conversation with Alexis Komor, PhD, who serves as deputy director of the Sanford Stem Cell Innovation Center and assistant professor in the Department of Chemistry and Biochemistry at UC San Diego. Not long after the discovery of CRISPR technology, Komor Identified how to edit DNA in a new, more precise way, down to a single base unit in the DNA sequence. Komor's contributions in teaching, mentoring, and research have been recognized with many awards, including the Cottrell Scholar Award, the "Talented 12" recognition by C&EN News, an NSF Faculty Early Career Development (CAREER) award, a U.S. National Institutes of Health early stage investigator Maximizing Investigators' Research Award (MIRA), and a "40 under 40" recognition in healthcare by Fortune magazine. Hosted by Bobby Gordon, MA, MBA. This episode was recorded on July 7, 2025, and information presented is accurate as of this date.
    Más Menos
    38 m